Skip to main content

Table 3 Oxidative stress markers of the study groups (mean ± SD)

From: Rosuvastatin attenuates contrast-induced nephropathy through modulation of nitric oxide, inflammatory responses, oxidative stress and apoptosis in diabetic male rats

  NDCM (n = 8) D (n = 8) DR (n = 8) DCM (n = 8) DRCM (n = 8)
Kidney TBARS (nmol/g) 36.21 ± 5.21# 30.23 ± 6.30 29.38 ± 5.38 42.62 ± 6.12* 32.26 ± 4.28
Serum MDA (μmol/l) 7.23 ± 1.12# 3.03 ± 0.52 3.18 ± 0.61 9.25 ± 1.23* 4.56 ± 0.78+
Serum Thiol (μmol/l) 287.78 ± 29.23# 362.25 ± 58.16 343.16 ± 62.11 247.16 ± 23.87* 346.19 ± 30.18**
Serum PCC (μmol/l) 10.11 ± 1.34# 7.68 ± 1.21 8.12 ± 0.92 14.23 ± 1.73* 8.38 ± 1.19**
  1. NDCM: non-diabetic rats + contrast media, D: diabetic group, DCM: diabetic rats + contrast media, DR: diabetic rats + rosuvastatin, DRCM: diabetic rats + rosuvastatin + contrast media.
  2. *P < 0.01 vs NDCM, D, DR and DRCM; + P < 0.05 vs NDCM, D and DR; # P < 0.05 vs D, DR; **P < 0.05 vs NDCM.